@article{fdi:010082596,
  title = {{P}articipating in a vaccine trial for {COVID}-19 in {S}enegal : trust and information},
  author = {{R}idde, {V}al{\'e}ry and {B}a, {M}. {F}. and {G}aye, {I}. and {D}iallo, {A}. {I}. and {B}onnet, {E}mmanuel and {F}aye, {A}.},
  editor = {},
  language = {{ENG}},
  abstract = {{T}his research aims to understand the level and determinants of people's willingness to participate in a vaccine trial for {COVID}-19 in {S}enegal. {W}e conducted a telephone survey among a marginal quota sample of 607 people over 18 years of age. {O}nly 44.3% of the participants wanted to participate in a vaccine trial for {COVID}-19, with females intending to participate more than males ({AOR} = 1.82, 95% {CI} [1.22-2.72]). {P}articipants who intended to be vaccinated against {COVID}-19 ({AOR} = 6.48, 95% {CI} [4.12-10.4]) and who thought that being infected with the coronavirus would have a significant impact on their health ({AOR} = 2.34, 95% {CI} [1.57, 3.51]) were more likely to agree to take part in the {COVID}-19 vaccine trial. {C}onfidence in the vaccine, health personnel, and the government in the fight against the pandemic are key factors in participants' willingness to participate in a vaccine trial in {S}enegal.},
  keywords = {{V}accine trial ; {COVID}-19 ; {S}enegal ; acceptability ; participation ; {SENEGAL}},
  booktitle = {},
  journal = {{H}uman {V}accines and {I}mmunotherapeutics},
  volume = {17},
  numero = {11},
  pages = {3907--3912},
  ISSN = {2164-5515},
  year = {2021},
  DOI = {10.1080/21645515.2021.1951097},
  URL = {https://www.documentation.ird.fr/hor/fdi:010082596},
}